Chad Allen Johnson insider trades

Open-market stock purchases and sales by Chad Allen Johnson, Director at Lumos Pharma, Inc, from SEC Form 4 filings since May 23, 2018.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • (LUMO) Lumos Pharma, Inc: other filings, last Dec 12, 2024
  • (NLNK) Newlink Genetics Corp: other filings, last Jul 31, 2019

Get free alerts when Chad Allen Johnson files a new trade →